Janssen to work with Resonant on cancer drug validation
Following a J&J Innovation award, Resonant becomes a partner of Janssen to work on the discovery and validation of antibody therapeutics for cancer.
Archives for December 17, 2019
Biologics patent protection provision pulled from Trump trade deal
The Trump Administration removes biologics patent provision from North American trade deal.